🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary aim of this study is to evaluate the efficacy of rimegepant on ...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2024-06-06
Trial ID
NCT06221111
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of daily an...
Status
Completed
Location
AMR Clinical
Start Date
2022-03-04
Trial ID
NCT05217927
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of rimegepa...
Status
Completed
Location
San Diego Clinical Research Center
Start Date
2022-02-17
Trial ID
NCT05248997
Treatments Being Tested
The purpose of this study is to assess whether galcanezumab is superior to ...
Status
Completed
Location
Gilbert Neurology
Start Date
2021-12-06
Trial ID
NCT05127486
Treatments Being Tested
The purpose of this study is to test the long-term safety of rimegepant in ...
Status
Recruiting
Location
Perseverance Research Center, LLC
Start Date
2021-04-28
Trial ID
NCT04743141
Treatments Being Tested
The goal of this observational study is to test the effectiveness and safet...
Status
Completed
Location
Ruijin-Hainan Hospital Shanghai Jiao Tong University School of Medicine
Start Date
2023-01-11
Trial ID
NCT05709106
Treatments Being Tested
Headaches affect over 50% of patients annually, with close to 4% of ED visi...
Status
Completed
Location
Maimonides Medical Center
Start Date
2021-04-22
Trial ID
NCT04860713
Treatments Being Tested
Single-center, open label, prospective study conducted at Medstar Georgetow...
Status
Recruiting
Location
MedStar Health: Neurology at McLean
Start Date
2025-09-09
Trial ID
NCT07301008
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of rimegepa...
Status
Terminated
Location
Bruce Nelson, DDS
Start Date
2022-05-05
Trial ID
NCT05262517
Treatments Being Tested
This study evaluates the effectiveness of rimegepant 75 mg orally disintegr...
Status
Terminated
Location
Mount Sinai Hospital
Start Date
2025-06-05
Trial ID
NCT06985342
Treatments Being Tested